Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 2 hours ago
BIO 2026: How a gut feeling transformed cancer treatment forever
about 2 hours ago
Dr. Israel Lowy remembers the days when he and his oncology immunotherapy...
Otsuka posts phase 3b ADHD trial win ahead of looming FDA approval decision
about 2 hours ago
A phase 3b trial of Otsuka’s attention-deficit/hyperactivity disorder prospect has hit its...
With $15M discovery deal, Boehringer becomes latest Big Pharma to buy into Immunai’s AI platform
about 3 hours ago
TechBio outfit Immunai is continuing its parade of Big Pharma partnerships with...
FDA drops blood pressure device enforcement against Whoop
about 3 hours ago
The FDA has sent an End of Enforcement notice to consumer wearable...
Ionis bags $30M from Recordati for ex-US rights to near-approval rare disease prospect
about 5 hours ago
Ionis Pharmaceuticals has offloaded regional rights to its near-approval rare disease asset...
Spurned by FDA, Passage Bio finds exit through merger with Remix
about 18 hours ago
Passage Bio, the Philadelphia-based gene therapy outfit that launched a strategic review...
Icon names Microsoft tech partner as Q1 results grow analyst confidence
about 20 hours ago
Irish CRO giant Icon this week made Microsoft its technology partner as...
Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief
about 21 hours ago
Officials are planning to study Mapp Biopharmaceutical’s MBP134 and Gilead Sciences’ remdesivir...
Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
1 day ago
After a four-month investigation, Nature Medicine has decided to pull a viral...
RQ Bio reels in $115M to take long-acting flu prevention antiviral into clinic
1 day ago
Amid a bustling fundraising week for biotechs, the U.K.’s RQ Bio is...
Novartis pays Antares $105M to illuminate undruggable cancer targets
1 day ago
Novartis is paying Antares Therapeutics $105 million upfront in a deal worth...
Abbott pens blood-based Alzheimer's testing pact with ALZpath
1 day ago
Abbott has become the latest company to team up with Alzheimer’s disease...